Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Al, Brockman"'
Autor:
Verena Ilona Carrara, Supakit Sirilak, Janjira Thonglairuam, Chaiporn Rojanawatsirivet, Stephane Proux, Valery Gilbos, Al Brockman, Elizabeth A Ashley, Rose McGready, Srivicha Krudsood, Somjai Leemingsawat, Sornchai Looareesuwan, Pratap Singhasivanon, Nicholas White, François Nosten
Publikováno v:
PLoS Medicine, Vol 3, Iss 6, p e183 (2006)
BackgroundEarly diagnosis and treatment with artesunate-mefloquine combination therapy (MAS) have reduced the transmission of falciparum malaria dramatically and halted the progression of mefloquine resistance in camps for displaced persons along the
Externí odkaz:
https://doaj.org/article/8856c6d9961c45be926b83b2d6118541
Autor:
François Nosten, Elizabeth A. Ashley, Stephane Proux, Rose McGready, Nicholas J. White, Robert Hutagalung, Anna Annerberg, Jahser Wilahphaingern, T Singtoroj, Pratap Singhasivanon, Al Brockman, Kasia Stepniewska, Gilvary Hla, Niklas Lindegardh
Publikováno v:
Tropical Medicine & International Health. 12:201-208
Summary Background Adherence to antimalarial drug regimens is improved by simple dosing. If the fixed antimalarial drug combination artemether–lumefantrine (AL) could be given once daily, this should improve adherence and thus effectiveness and low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47dd178335c804d15ac7fb322e8de749
https://doi.org/10.1111/j.1365-3156.2006.01785.x
https://doi.org/10.1111/j.1365-3156.2006.01785.x
Autor:
Anna Annerberg, Kasia Stepniewska, Nicholas J. White, Elizabeth A. Ashley, François Nosten, Am Kham, Pratap Singhasivanon, Niklas Lindegardh, Al Brockman
Publikováno v:
Tropical Medicine & International Health. 12:195-200
Summary Background Artemether–lumefantrine (AL) is the only fixed, artemisinin-based combination antimalarial drug which is registered internationally and deployed on a large scale. Absorption of the hydrophobic lipophilic lumefantrine component va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7709a60f466847a2830460048f0be944
https://doi.org/10.1111/j.1365-3156.2006.01784.x
https://doi.org/10.1111/j.1365-3156.2006.01784.x
Autor:
Elizabeth A, Ashley, Kasia, Stepniewska, Niklas, Lindegårdh, Anna, Annerberg, Am, Kham, Al, Brockman, Pratap, Singhasivanon, Nicholas J, White, François, Nosten
Publikováno v:
Tropical medicineinternational health : TMIH. 12(2)
Artemether-lumefantrine (AL) is the only fixed, artemisinin-based combination antimalarial drug which is registered internationally and deployed on a large scale. Absorption of the hydrophobic lipophilic lumefantrine component varies widely between i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3b72dbfdef0f8f313aca6525e90968f
https://pubmed.ncbi.nlm.nih.gov/17300625
https://pubmed.ncbi.nlm.nih.gov/17300625
Autor:
Elizabeth A, Ashley, Kasia, Stepniewska, Niklas, Lindegårdh, Rose, McGready, Anna, Annerberg, Robert, Hutagalung, Thida, Singtoroj, Gilvary, Hla, Al, Brockman, Stephane, Proux, Jahser, Wilahphaingern, Pratap, Singhasivanon, Nicholas J, White, François, Nosten
Publikováno v:
Tropical medicineinternational health : TMIH. 12(2)
Adherence to antimalarial drug regimens is improved by simple dosing. If the fixed antimalarial drug combination artemether-lumefantrine (AL) could be given once daily, this should improve adherence and thus effectiveness and lower the risk of select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cf86ac245a1252184693c8aa26c8e38f
https://pubmed.ncbi.nlm.nih.gov/17300626
https://pubmed.ncbi.nlm.nih.gov/17300626
Autor:
Tim J. Anderson, Michèle van Vugt, Denae Nash, Sanjeev Krishna, Ric N. Price, François Nosten, Robert Hutagalung, Anne-Catrin Uhlemann, Shalini Nair, Al Brockman, Pratap Singhasivanon, Nicholas J. White
Publikováno v:
Clinical infectious diseases, 42(11), 1570-1577. Oxford University Press
The emergence of drug resistance in Plasmodium falciparum has significantly undermined malaria-control programs in countries where it is endemic [1]. To ensure high cure rates and to combat this threat, the World Health Organization (WHO) has recomme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbca56c1ab700dd482f67eff8bd4c64e
http://ora.ox.ac.uk/objects/uuid:6a819529-2a7c-48e7-9294-9e6b81d51920
http://ora.ox.ac.uk/objects/uuid:6a819529-2a7c-48e7-9294-9e6b81d51920
Autor:
Blessing NA; Department of Biological Sciences, The University of Toledo, Toledo, Ohio, USA., Brockman AL; Department of Biological Sciences, The University of Toledo, Toledo, Ohio, USA., Chadee DN; Department of Biological Sciences, The University of Toledo, Toledo, Ohio, USA deborah.chadee@utoledo.edu.
Publikováno v:
Molecular and cellular biology [Mol Cell Biol] 2014 Aug; Vol. 34 (16), pp. 3132-43. Date of Electronic Publication: 2014 Jun 09.